1. Home
  2. BRTX vs AMBO Comparison

BRTX vs AMBO Comparison

Compare BRTX & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • AMBO
  • Stock Information
  • Founded
  • BRTX 1997
  • AMBO 2000
  • Country
  • BRTX United States
  • AMBO United States
  • Employees
  • BRTX N/A
  • AMBO N/A
  • Industry
  • BRTX Managed Health Care
  • AMBO Other Consumer Services
  • Sector
  • BRTX Health Care
  • AMBO Real Estate
  • Exchange
  • BRTX Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • BRTX 12.5M
  • AMBO 10.5M
  • IPO Year
  • BRTX N/A
  • AMBO 2010
  • Fundamental
  • Price
  • BRTX $1.43
  • AMBO $3.72
  • Analyst Decision
  • BRTX
  • AMBO
  • Analyst Count
  • BRTX 0
  • AMBO 0
  • Target Price
  • BRTX N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • BRTX 102.2K
  • AMBO 24.4K
  • Earning Date
  • BRTX 11-11-2025
  • AMBO 08-05-2025
  • Dividend Yield
  • BRTX N/A
  • AMBO N/A
  • EPS Growth
  • BRTX N/A
  • AMBO N/A
  • EPS
  • BRTX N/A
  • AMBO 0.69
  • Revenue
  • BRTX $605,200.00
  • AMBO $9,699,000.00
  • Revenue This Year
  • BRTX $232.67
  • AMBO N/A
  • Revenue Next Year
  • BRTX $52.92
  • AMBO N/A
  • P/E Ratio
  • BRTX N/A
  • AMBO $5.39
  • Revenue Growth
  • BRTX 247.62
  • AMBO 23.73
  • 52 Week Low
  • BRTX $1.21
  • AMBO $1.00
  • 52 Week High
  • BRTX $2.55
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 37.54
  • AMBO 59.03
  • Support Level
  • BRTX $1.56
  • AMBO $3.44
  • Resistance Level
  • BRTX $1.63
  • AMBO $3.81
  • Average True Range (ATR)
  • BRTX 0.10
  • AMBO 0.35
  • MACD
  • BRTX -0.02
  • AMBO 0.01
  • Stochastic Oscillator
  • BRTX 0.00
  • AMBO 90.00

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: